|
FDA issues Caution for Tamiflu
Tamiflu (oseltamivir phosphate) is used to treat some types of influenza infection (the “flu”) in adults and children over the age of 1 who flu symptoms have only been noted for two days or less. Tamiflu has also been used in the same population listed above when they spend time with someone who has the flu or during a flu outbreak. Tamiflu works by stopping the growth and spread of the flu virus in the body, thereby decreasing the time an individual experiences the symptoms common with the flu.
Countries around the world have been stock piling this type of medication in case a worldwide flu pandemic erupts. However, concerns about psychiatric problems were brought to light last year after twelve children in Japan were noted to have died, and thirty-two experienced abnormal behavior after they took Tamiflu. Since those reports, the FDA has evaluated 103 reports of psychiatric problems from August 2005 to July of 2006. A large majority of the cases came from Japan, and two-thirds of the ill effected population were under the age of 17.
As a result, FDA officials felt it was important to issue the caution, which strongly recommends close monitoring of patients for abnormal behavior such as delirium and self-injury. A caution is a less serious note on a drug label than a warning. It is still not certain that the drug contributed to any of the reports of psychiatric problems.
The manufacturer of Tamiflu, Roche, added the new language to packet inserts and sent letters to the healthcare community regarding the new cautions. Roche pointed out that the psychiatric problems are rare given that Tamiflu has been administered to over 42 million people since 1999.
Contact our office to learn more about our extensive ability to assist your practice with cases like this. Our services would include:
Medical Record Assessment and Case Analysis
- Identify, locate, review and interpret relevant medical records
- Organize, tab and paginate medical records for easy reference
- Prepare chronologies of the medical events involved in a case
- Summarize, translate and clarify medical records
- Identification and summation of applicable standards of care
- Determine adherences to and deviation from applicable standards of care
- Identify causation issues
- Assess damages and injuries
- Identify contributing factors
- Identify potential defendants
- Construct written reports for attorney-client use
Case Support
- Research medical and nursing literature for integration into case analysis
- Analyze the validity of research used by all parties
- Interview plaintiff and defense clients, key witnesses and experts
- Consult with healthcare providers regarding injuries, causation and damages
Coordination with Experts and Other Witnesses
- Identify types of experts needed for the case
- Locate needed experts
- Investigate potential expert witnesses, review their work product and publications
- Assist in preparation of witnesses and experts for deposition and trial
Discovery and Court Preparation Support
- Prepare questions for deposition or trial examination
- Prepare medical aspects of interrogatories and requests for production
- Review and draft responses to various legal documents
- Analysis and summation of deposition and past testimony
- Assist with demonstrative evidence preparation
- Assist in resolution of cases through alternative dispute resolution
References used:
Richwine, L. Tamiflu label will carry new caution in U.S. Retrieved December 2006 from http://www/nlm.nih.gov/medlineplus/new/fullstory_41278.html
Medline Drug Information: Ostelamivir. Retrieved December 2006 from http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699040.html
For more information on this issue please
see Contact Us
and see how our services can work for you.
|